GLOBOCAN is the world's cancer numbers: incidence and mortality estimates for 185 countries and 36 cancers.
GLOBOCAN, presented through the Global Cancer Observatory, provides the world's cancer numbers: incidence and cancer death estimates for 185 countries and 36 cancers. It is produced by the International Agency for Research on Cancer (IARC / WHO) and is free to use. The observatory is organised into Cancer Today for current estimates, Cancer Tomorrow for projections and Cancer Over Time for trends. On OnCo it is cited by the bottlenecks The hardest cancers are found late, Prevention we already have is not deployed, Most of the world has almost no cancer care and Funding follows fashion, not burden, and by ideas such as A public map of trial deserts to steer where new sites open and Make a population cancer registry a condition of every cancer aid programme.
Shares A public tracker of how long each country takes to adopt new evidence, A public dashboard of research money per death for every cancer, Make a population cancer registry a condition of every cancer aid programme, Set trial enrolment targets from who actually gets the disease, and publish progress live.
Shares Cancer epidemiology, The hardest cancers are found late, Most of the world has almost no cancer care, Gallbladder cancer.
Shares The Lancet Global Health, World Health Organization Cancer Programme, International Agency for Research on Cancer (IARC / WHO).
Shares Open-source cancer registry-in-a-box for low-resource settings, Weak real-world evidence and registries, Most of the world has almost no cancer care.
Shares American Cancer Society (ACS), World Health Organization Cancer Programme, International Agency for Research on Cancer (IARC / WHO), Most of the world has almost no cancer care.
Shares World Health Organization Cancer Programme, International Agency for Research on Cancer (IARC / WHO), Prevention we already have is not deployed, The hardest cancers are found late.
Shares A public dashboard of research money per death for every cancer, International Agency for Research on Cancer (IARC / WHO), Funding follows fashion, not burden.
Shares A burden-to-funding audit for gallbladder cancer and a dedicated research call, Funding follows fashion, not burden, Gallbladder cancer.